Effect of fufang xueshuantong capsule on a rat model of retinal vein occlusion

Chinese Journal of Integrative Medicine

Volumn 17, Issue 4, 2011, Pages 296-301

  Yuan, Yuan Zhi ^a   Yuan, Fei ^a   Xu, Qin Yue ^a   Yu, Jia ^a   Li, Lei ^a   Zhang, Ju Li ^a  

^a FUDAN UNIVERSITY   (China)

Author keywords

Animal model; Fufang xueshuantong capsule; Retinal vein occlusion; Stromal cell derived factor 1; Vascular endothelial growth factor

Indexed keywords

FUFANG XUESHUANTONG; HERBACEOUS AGENT; ID 080401; MESSENGER RNA; STROMAL CELL DERIVED FACTOR 1; UNCLASSIFIED DRUG; VASCULOTROPIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG CAPSULE; DRUG EFFECT; FLUORESCENCE ANGIOGRAPHY; GENE EXPRESSION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; REAL TIME POLYMERASE CHAIN REACTION; RETINA BLOOD FLOW; RETINA BLOOD VESSEL; RETINA CAPILLARY; RETINA DETACHMENT; RETINA HEMORRHAGE; RETINA VEIN OCCLUSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VEIN THROMBOSIS;

ANIMALS; BASE SEQUENCE; CHEMOKINE CXCL12; DISEASE MODELS, ANIMAL; DNA PRIMERS; DRUGS, CHINESE HERBAL; FLUORESCEIN ANGIOGRAPHY; GENE EXPRESSION; MALE; RATS; RATS, SPRAGUE-DAWLEY; RETINAL VEIN OCCLUSION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 79960110965     PISSN: 16720415     EISSN: 19930402     Source Type: Journal    
DOI: 10.1007/s11655-011-0690-6     Document Type: Article

References (25)

1. Lim LL, Cheung N, Wang JJ, Islam FM, Mitchell P, Saw SM, et al. Prevalence and risk factors of retinal vein occlusion in an Asian population. Br J Ophthalmol 2008;92:1316-1319.
2. Mitchell P, Smith W, Chang A. Prevalence and associations of retinal vein occlusion in Australia: The Blue Mountains Eye Study. Arch Ophthalmol 1996;114:1243-1247. (Pubitemid 26338856)
3. Yuan YZ, Yuan F. Clinical and fundus fluorescein angiography characteristics of 116 patients with retinal vein occlusion. Chin J Clin Med (Chin) 2004;11:626-627.
4. Wong TY, Scott IU. Clinical practice. Retinal-vein occlusion. N Engl J Med 2010;363:2135-2144.
5. Zhang Y, Fortune B, Atchaneeyasakul LO, McFarland T, Mose K, Wallace P, et al. Natural history and histology in a rat model of laser-induced photothrombotic retinal vein occlusion. Curr Eye Res 2008;33:365-376. (Pubitemid 351507765)
6. Shahid H, Hossain P, Amoaku WM. The management of retinal vein occlusion: Is interventional ophthalmology the way forward? Br J Ophthalmol 2006;90:627-639.
7. Gao D, Song J, Hu J, Lin J, Zheng L, Cai J, et al. Angiogenesis promoting effects of Chinese herbal medicine for activating blood circulation to remove stasis on chick embryo chorio-allantoic membrane. Chin J Integr Tradit West Med (Chin) 2005;25:912-915.
8. Ham DI, Chang K, Chung H. Preretinal neovascularization induced by experimental retinal vein occlusion in albino rats. Korean J Ophthalmol 1997;11:60-64.
9. Saito Y, Park L, Skolik SA, Alfaro DV, Chaudhry NA, Barnstable CJ, et al. Experimental preretinal neovascularization by laser-induced venous thrombosis in rats. Curr Eye Res 1997;16:26-33. (Pubitemid 27085149)
10. Kang SG, Chung H, Hyon JY. Experimental preretinal neovascularization by laser-induced thrombosis in albino rats. Korean J Ophthalmol 1999;13: 65-70.
11. Lai CC, Wu WC, Chuang LH, Yeung L, Wei W, Yang KJ. Quantitative grading of preretinal neovascularization in adult rats. Acta Ophthalmol Scand 2005;83:590-594. (Pubitemid 41488634)
12. Yuan YZ, Yuan F, Li L, Wang Y, Tong BY. Expression of stromal cell-derived factor 1 is increased in the retina of experimental diabetic rats. Chin J Ophthalmol (Chin) 2007;43:912-916.
13. Butler JM, Guthrie SM, Koc M, Afzal A, Caballero S, Brooks HL, et al. SDF-1 is both necessary and sufficient to promote proliferative retinopathy. J Clin Invest 2005;115:86-93. (Pubitemid 40385508)
14. Vinores SA, Derevjanik NL, Vinores MA, Okamoto N, Campochiaro PA. Sensitivity of different vascular beds in the eye to neovascularization and blood-retinal barrier breakdown in VEGF transgenic mice. Adv Exp Med Biol 2000;476:129-138. (Pubitemid 32176132)
15. Simó R, Hernández C. Intravitreous anti-VEGF for diabetic retinopathy: Hopes and fears for a new therapeutic strategy. Diabetologia 2008;51:1574-1580.
16. Neuhaus T, Stier S, Totzke G, Gruenewald E, Fronhoffs S, Sachinidis A, et al. Stromal cell-derived factor 1alpha (SDF-1alpha) induces gene-expression of early growth response-1 (Egr-1) and VEGF in human arterial endothelial cells and enhances VEGF induced cell proliferation. Cell Prolif 2003;36:75-86. (Pubitemid 36532558)
17. Berker N, Batman C. Surgical treatment of central retinal vein occlusion. Acta Ophthalmol 2008;86:245-252. (Pubitemid 351785095)
18. Mohamed Q, McIntosh RL, Saw SM, Wong TY. Interventions for central retinal vein occlusion: An evidence-based systematic review. Ophthalmology 2007;114:507-519, 524.
19. McIntosh RL, Mohamed Q, Saw SM, Wong TY. Interventions for branch retinal vein occlusion: An evidence-based systematic review. Ophthalmology 2007;114:835-854.
20. Rehak J, Rehak M. Branch retinal vein occlusion: Pathogenesis, visual prognosis, and treatment modalities. Curr Eye Res 2008;33:111-131. (Pubitemid 351302200)
21. Margolis R, Singh RP, Kaiser PK. Branch retinal vein occlusion: Clinical findings, natural history, and management. Compr Ophthalmol Update 2006;7:265-276. (Pubitemid 46579459)
22. White CM, Fan C, Song J, Tsikouris JP, Chow M. An evaluation of the hemostatic effects of hydrophilic, alcohol, and lipophilic extracts of notoginseng. Pharmacotherapy 2001;21:773-777. (Pubitemid 32606790)
23. Cheng TO. Cardiovascular effects of Danshen. Int J Cardiol 2007;121:9-22. (Pubitemid 47287779)
24. Cho WC, Leung KN. In vitro and in vivo immunomodulating and immunorestorative effects of Astragalus membranaceus. J Ethnopharmacol 2007;113:132-141. (Pubitemid 47077858)
25. Wang S, Zheng Z, Weng Y, Yu Y, Zhang D, Fan W, et al. Angiogenesis and anti-angiogenesis activity of Chinese medicinal herbal extracts. Life Sci 2004;74:2467-2478. (Pubitemid 38324603)